AL 43546

Drug Profile

AL 43546

Alternative Names: AL-43,546

Latest Information Update: 10 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Alcon
  • Class Mannans
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • No development reported Dry eyes

Most Recent Events

  • 29 Jul 2015 No recent reports on development identified - Phase-II for Dry eyes in USA (Ophthalmic)
  • 29 Jul 2015 No recent reports on development identified - Phase-III for Dry eyes in Japan (Ophthalmic)
  • 31 Dec 2011 Phase-III clinical trials in Dry eyes in Japan (Ophthalmic)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top